Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Anna R Mäkelä

2PUBLICATIONS
16CO-AUTHORS
Speciation and extinctionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|May 04, 2026
Spike conformational tuning rather than epitope erosion drives SARS-CoV-2 resistance to broadly neutralizing antibodies.

|Mar 03, 2025
Engineered SH3-Derived Sherpabodies Function as a Modular Platform for Targeted T-cell Immunotherapy.

Rogelio A Hernández-López, Tapio Kesti, Anna R Mäkelä

Pageof 1

Frequent Collaborators

2 joint publications

Tapio Kesti

2 joint publications

Kalle Saksela

1 joint publications

Rogelio A Hernández-López

1 joint publications

Zhe Zhao

1 joint publications

Wei Yu

1 joint publications

Yurie Tonai

1 joint publications

Hector J Monzo

1 joint publications

Kerttu Kalander

1 joint publications

Sirpa Leppä

1 joint publications

Päivi M Ojala

Frequent Collaborators

2 joint publications

Tapio Kesti

2 joint publications

Kalle Saksela

1 joint publications

Rogelio A Hernández-López

1 joint publications

Zhe Zhao

Top Related Videos

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance
13:00

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance

Published on : Jun 14, 2022

2.2K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.5K
See more related videos

Top Related Videos

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance
13:00

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance

Published on : Jun 14, 2022

2.2K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.5K
See more related videos